Print
Category: Uncategorised
Hits: 1003
Diagnostic groups and subgroups    < 1 an    1-4 ans 5-9 ans  10-14 ans  
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases 60.0 [54.9-64.7] 89.2 [88.0-90.2] 88.5 [87.0-89.8] 79.7 [77.5-81.6] **
I.a Lymphoid leukemias 52.3 [44.1-59.8] 93.6 [92.6-94.5] 90.8 [89.2-92.1] 83.5 [81.1-85.7] **
I.b Acute myeloid leukemias 64.4 [56.3-71.3] 63.2 [57.8-68.2] 81.1 [75.3-85.7] 65.7 [59.9-70.8] **
II. Lymphomas and reticuloendothelial neoplasms 90.9 [50.8-98.7] 92.1 [88.5-94.6] 94.2 [92.4-95.6] 94.1 [92.8-95.2]  
II.a Hodgkin lymphomas - [-] 100.0 [-] 98.3 [95.5-99.4] 96.9 [95.5-97.9]  
II.b Non-Hodgkin lymphomas (except Burkitt lymphomas) 90.0 [47.3-98.5] 86.1 [78.8-91.0] 89.4 [85.1-92.5] 89.9 [86.5-92.5]  
II.c Burkitt lymphomas 100.0 [-] 95.4 [90.7-97.8] 95.3 [92.4-97.2] 90.3 [85.3-93.7]  
III. CNS and miscellaneous intracranial and intraspinal neoplasms 62.1 [57.3-66.6] 70.8 [68.7-72.7] 71.3 [69.2-73.2] 80.5 [78.5-82.4] **
III.a Ependymomas and choroid plexus tumors 71.0 [60.0-79.5] 65.1 [58.6-70.8] 80.1 [71.5-86.4] 86.5 [78.5-91.6] **
III.b Astrocytomas 80.6 [72.4-86.6] 93.6 [91.6-95.1] 81.7 [78.7-84.3] 82.2 [78.8-85.1] **
III.c Intracranial and intraspinal embryonal tumors 25.0 [17.3-33.4] 36.7 [32.2-41.2] 67.5 [62.6-71.9] 79.1 [72.7-84.1] **
III.d Other gliomas 74.9 [55.9-86.6] 42.5 [35.8-49.1] 25.4 [20.8-30.2] 45.4 [39.1-51.4] **
III.e Other specified intracranial and intraspinal neoplasms 83.8 [70.0-91.6] 93.9 [89.7-96.4] 95.0 [92.2-96.8] 96.3 [94.2-97.7] **
IV. Neuroblastomas and other peripheral nervous cell tumors 90.2 [87.8-92.0] 66.8 [63.6-69.7] 62.5 [55.4-68.7] 65.3 [52.3-75.5] **
IV.a Neuroblastomas and ganglioneuroblastomas 90.2 [88.0-92.1] 66.6 [63.5-69.6] 62.7 [55.6-69] 55.8 [41.1-68.3] **
V. Retinoblastomas 99.4 [97.5-99.8] 98.9 [97.0-99.6] 100.0 [-] 100.0 [-]  
VI. Renal tumors 89.3 [84.2-92.8] 94.1 [92.3-95.5] 93.2 [89.6-95.6] 88.1 [76.7-94.2] *
VI.a Nephroblastomas and other nonepithelial renal tumors 89.3 [84.2-92.8] 94.1 [92.3-95.5] 93.4 [89.6-95.9] 88.9 [73.0-95.7] *
VII. Hepatic tumors 87.7 [76.8-93.6] 86.4 [79.0-91.3] 71.8 [49.4-85.6] 58.9 [40.2-73.6] **
VII.a Hepatoblastomas 87.5 [76.5-93.5] 86.7 [79.2-91.6] 70.6 [43.1-86.6] 44.4 [13.6-71.9] **
VIII. Malignant bone tumors 80.0 [20.4-96.9] 71.4 [58.8-80.8] 74.6 [69.6-79.0] 73.2 [69.7-76.4]  
VIII.a Osteosarcomas 100.0 [-] 51.9 [22.5-75.0] 70.4 [62.2-77.2] 71.6 [66.6-76.0]  
VIII.c Ewing tumors and related bone sarcomas 66.7 [5.4-94.5] 75.7 [61.1-85.5] 77.0 [69.7-82.7] 73.0 [67.3-77.9]  
IX. Soft tissue and other extraosseous sarcomas 70.2 [62.7-76.5] 73.8 [69.5-77.5] 74.0 [69.4-77.9] 68.5 [64.0-72.6]  
IX.a Rhabdomyosarcomas 83.2 [69.9-90.9] 74.9 [70.1-79.1] 71.7 [65.7-76.8] 62.8 [54.4-70.1] **
IX.b Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms 90.0 [77.5-95.7] 90.9 [50.8-98.7] 74.9 [45.6-89.9] 57.0 [39.0-71.6] **
IX.d Other specified soft tissue sarcomas 38.8 [25.7-51.8] 72.4 [61.8-80.4] 79.6 [71.0-85.8] 73.4 [67.0-78.7] **
IX.e Unspecified soft tissue sarcomas 63.5 [33.1-83.0] 44.7 [21.8-65.4] 69.5 [49.1-83.1] 71.9 [57.1-82.4]  
X. Germ-cell tumors, trophoblastic tumors, and neoplasms of gonads 91.1 [86.6-94.2] 95.8 [91.7-97.9] 96.8 [91.8-98.8] 92.8 [89.7-95.0]  
X.a Intracranial and intraspinal germ cell tumors 90.0 [72.0-96.7] 92.5 [83.0-96.8] 95.6 [86.9-98.6] 94.3 [89.7-96.9]  
X.b Malignant extracranial and extragonadal germ cell tumors 89.1 [83.0-93.1] 95.6 [86.8-98.5] 100.0 [-] 84.8 [64.2-94.0]  
X.c Malignant gonadal germ cell tumors 100.0 [-] 100.0 [-] 100.0 [-] 95.1 [90.4-97.5]  
XI. Other malignant epithelial neoplasms and malignant melanomas 96.4 [77.2-99.5] 86.7 [76.6-92.6] 92.7 [87.5-95.8] 93.2 [90.6-95.1]  
XI.b Thyroid carcinomas 100.0 [-] 100.0 [-] 98.6 [90.5-99.8] 98.7 [96.0-99.6]  
XI.d Malignant melanomas 100.0 [-] 76.7 [52.5-89.7] 89.5 [74.3-95.9] 88.9 [79.6-94.1]  
XII. Other and unspecified malignant neoplasms 90.0 [47.3-98.5] 78.6 [58.4-89.8] 85.7 [33.4-97.9] 55.6 [20.4-80.5]  
All cancers (excluding LCH) 81.0 [79.4-82.4] 82.4 [81.6-83.2] 81.7 [80.7-82.6] 83.0 [82.1-83.9] **
Langherhans cell histiocytosis 87.0 [73.2-93.9] 95.9 [84.7-99.0] 100.0 [-] 100.0 [-]  
All cancers (including LCH) 81.1 [79.5-82.5] 82.5 [81.7-83.3] 81.7 [80.7-82.7] 83.0 [82.1-83.9] **

p : pvalue of the logrank test (* <0.05; ** < 0.01)

5-year overall survival rates of childhood cancer in mainland France over 2000-2014, by diagnostic and age groups